1. Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual.
- Author
-
Yeoh K, Lass-Flörl C, Lamoth F, Slavin MA, Williams E, and Neofytos D
- Subjects
- Humans, Middle Aged, Female, Transplantation, Homologous adverse effects, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Cytarabine therapeutic use, Cytarabine administration & dosage, Induction Chemotherapy, Leukemia, Myeloid, Acute therapy, Leukemia, Myeloid, Acute complications, Multiple Myeloma therapy, Hematopoietic Stem Cell Transplantation adverse effects
- Abstract
This case involves a 53-year-old female with concurrent acute myeloid leukemia (AML) and multiple myeloma. She underwent cytarabine and daunorubicin (7+3) induction chemotherapy followed by cytarabine (HiDAC) consolidation, with an early AML relapse requiring azacitidine and venetoclax therapy. She achieved complete remission and incomplete count recovery. Following fludarabine, melphalan, and thymoglobulin induction chemotherapy, she underwent an allogeneic stem cell transplant with failure to engraft, requiring autologous stem cell rescue, buffy coat, and granulocyte transfusions, eventually presenting with a diffuse skin rash consistent with Steven-Johnson syndrome and toxic epidermal necrolysis, persistent neutropenic fevers and positive blood cultures., (© 2024 The Authors. Transplant Infectious Disease published by Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF